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Abstract 
 
Polyphenols have been suggested to reduce body weight and modify body 
composition through different mechanisms. These effects have been extensively 
studied in animals and in vitro and to a lesser extent in humans. The aim of this 
review is to consider the association between polyphenols and body weight status by 
focusing on human intervention studies. We conducted a systematic literature search 
in MEDLINE (via EBSCOhost), ProQuest CENTRAL and Cochrane CENTRAL 
without time restrictions. Randomized controlled trials (RCTs) assessing the effect of 
polyphenols on weight and/or body composition in the overweight and/or obese 
population were included. Nineteen studies met our inclusion criteria. Results 
suggest that further research is required before supporting a potential role of 
polyphenols in reducing weight in overweight and obese individuals (9 studies 
showed a significant decrease in weight by a mean of 1.47±0.58 Kg). Nevertheless, 
several studies indicated that polyphenols might be effective in preventing small 
increases in weight during periods of overfeeding rather than reducing weight as 
such. The outcomes noted do not yet support polyphenol supplementation as a 
complementary approach in weight-loss diets. Further larger trials with duration of 12 
months or more are needed to elucidate the effect of polyphenols on body weight 
status. 
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Introduction  
 
Polyphenols are vastly diverse phytochemicals with complex chemical structures. 
They are found in a variety of commonly consumed foods such as chocolate, tea, 
coffee, wine, olive, dry legumes, and some vegetables (like lettuce and cabbage) 
and fruits (like apples and berries) (Manach et al., 2004; D’archivio et al., 2007). 
Around 8000 structures of polyphenols have been already identified (Martin et al., 
2010). Polyphenols are classified into four groups: flavonoids, lignans, stilbenes and 
phenolic acids (Manach et al., 2004). Figure 1 summarizes the most common 
polyphenols and their subtypes. 
Polyphenols have been extensively studied over the past decade because of their 
potential antioxidant and anti-inflammatory roles and their possible role in the 
prevention and management of several diseases such as cardiovascular diseases 
(CVD), hypertension, diabetes, cancer, and neurodegenerative diseases (Manach et 
al., 2004; D’archivio et al., 2007; Michalska et al., 2010; Serban et al., 2015). Most 
recently, polyphenols have attracted media interest and research community 
because of their potential role in reducing obesity, an increasingly serious health 
issue in different population age ranges (Zaki et al., 2015; WHO 2016). Polyphenols 
such as catechins, anthocyanins, curcumin and resveratrol were suggested to exert 
beneficial effects on lipid and energy metabolism (Meydani et al., 2010; Min et al., 
2013; Gu et al., 2014; Kunnumakkara et al., 2016; Smeriglio et al., 2016) and 
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potentially on weight status. Multiple mechanisms of action have been proposed 
mostly as a result of animal and cell studies, such as inhibition of the differentiation 
of adipocytes (Min et al., 2013), increased fatty acid oxidation (Dulloo et al., 1999; 
Shimoda et al., 2009), decreased fatty acid synthesis (Matsui et al., 2005), increased 
thermogenesis and energy expenditure (Nagao et al., 2007; Osakabe et al., 2013; 
Stohs and Badmaev, 2016) and inhibition of digestive enzymes (McDougall et al., 
2005; Gu et al., 2011). Despite the popularity of this topic, the biggest contribution to 
this research remains through animal and in vitro studies. Few cohort studies have 
looked at the association between polyphenol consumption and body weight in 
humans (Wu et al., 2003; Hughes et al., 2008; Golomb et al., 2012), and human 
intervention studies are outnumbered by animal and cell studies and remain 
relatively limited. Results from animal and in vitro studies have mostly indicated an 
effect of polyphenols on reducing obesity, and have considerably contributed to the 
obesity-lowering effects of polyphenols discussed in the media. However, many 
factors could affect the replication of these outcomes to humans. Firstly, there are 
many differences in the metabolism and mechanism of actions of polyphenols 
between animals and humans (Natsume et al., 2003). For example, there is lack of 
clear evidence of the presence of biologically active brown adipose tissue in adults, 
the latter being demonstrated to be primarily triggered by cold exposure in humans 
(Chen et al., 2013). This has explained a part of the weight lowering effect of cocoa 
and tea polyphenols in animals (Matsui et al., 2005; Nomura et al., 2008). Secondly, 
there is a difference in body weight control between animals and free living humans. 
The latter exhibit large differences in daily levels of physical activity and energy 
balance (Leibel, 2008). Thirdly, the complexity of substituting in vitro studies for 
humans studies relies in the limitations in assessing polyphenol bioavailability in cell 
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studies (Etcheverry et al., 2012). Also, the doses of polyphenols that exert a 
significant effect on obesity in cells (such as the inhibition of adipogenesis (Min et al., 
2013; Ejaz et al., 2009)) can be higher than the physiological levels. In view of these 
potential differences, and for the aim of helping the public make informed choices 
and directing future research, we attempt to consider the association between 
polyphenols and body weight status through conducting a systematic review of 
human intervention studies. 
 
Methods 
 
The review preparation was completed in 7 steps: Identification of research question, 
definition of inclusion and exclusion criteria, literature search, selection of eligible 
studies, data extraction, evaluation of the risk of bias (through the Cochrane RoB 
Tool) and presentation of results (Cornell 2016). The review was prepared according 
to the Prisma guidelines (Moher et al., 2009). 
 
Search strategy 
 
We (GF, EAD) independently conducted a systematic literature search in MEDLINE 
(via EBSCOhost), ProQuest CENTRAL and Cochrane CENTRAL (from 11 
November 2016 to 10 December 2016) without any time restrictions. We used the 
following keywords: Polyphenol AND (Body weight OR Waist circumference OR Fat). 
We also searched the reference list of selected studies for more relevant research. 
Disagreements in the assessment of data were resolved by discussion and 
consensus was reached in all cases. 
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Eligibility criteria 
 
Studies included were human RCTs investigating as a main outcome the link 
between polyphenols and obesity (through measurement of body weight and/or waist 
circumference (WC), waist/hip ratio, or body fat at least twice during the study). 
There were no restrictions on the type of studies (parallel or crossover studies). 
Eligible studies included overweight and/or obese adults with no history of known 
diseases (diabetes, CVD or hypertension) and no intake of medications that could 
influence lipid, carbohydrate or energy metabolism. Studies involving exercise 
regimens and/or hypocaloric diets in addition to the polyphenol intervention were 
excluded. In addition, eligibility of studies was restricted to duration no less than 4 
weeks and to English language. To avoid confounding effects, studies investigating 
the combined effects of polyphenols and other components (such as tyrosine, fibre 
etc...) on anthropometric measures were excluded. Missing data and further 
information were requested from the authors.  
 
Study selection and data extraction 
 
References were checked for eligibility by two independent authors. Full texts were 
then verified against the inclusion criteria. Risk of bias was assessed and data about 
study design, participant information (BMI, age, gender) and outcome measures 
(Body weight, BMI, WC, waist-to-hip ratio and/or body fat percentage or mass) were 
extracted. Baseline and post intervention values and mean difference from baseline 
data were collected. 
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Results 
 
The search identified 19 eligible studies. The study selection process is summarised 
in Figure 2. 
 
Risk of bias 
 
The allocation concealment was considered to be suitable in 2 studies and unclear in 
17. Eighteen studies reported blinding participants and outcome assessors. Three 
studies described measures used to blind participants and outcome assessors. Data 
analysis of the main outcomes was reported by 15 studies. Incomplete outcome data 
was considered to be adequately handled in 10 studies. The two authors (GF, EAD) 
have reached a consensus on not to conduct a meta-analysis in this review for the 
following reasons 1) heterogeneity of the studies and the different types of 
polyphenols administered 2) missing outcome data that we failed to obtain from 
authors 3) missing information regarding allocation concealment and handling 
outcome data which makes it difficult to evaluate the risk of bias in studies. This 
might likely produce inappropriate summary and biased conclusions. Therefore, this 
review mainly aimed to clarify the effects of polyphenols on anthropometric 
measures and to provide directions for future research. 
 
Study characteristics 
 
Studies were conducted in Japan (N=5), USA (N=4), Germany (N=2), Spain (N=1), 
Taiwan (N=2), France (N=1), China (N=1), Denmark (N=1), Poland (N=1) and UK 
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(N=1). Studies investigated the effect of green tea (N=6), oolong tea (N=1), Licorice 
flavonoid oil (LFO) (N=3), apple juice (N=2), citrus extract (N=1), Hibiscus sabderiffa 
extract (N=1), grape juice (N=1), quercetin (N=1), Ecklonia cava (N=1), resveratrol 
(N=1) and orange juice (N=1). Samples sizes ranged from 22 to 240 participants. 
Sixteen studies were parallel, while 3 were crossover. All studies assessed body 
weight, 14 assessed waist circumference and 12 assessed body fat (percentage or 
mass). Four studies used a polyphenol-rich drink that provided energy, while 15 
studies used capsules or drinks that provided a negligible amount of calories. Four 
studies assessed the effect of different doses of polyphenols on anthropometric 
measures. Ten studies disclosed funding from industry, and 3 studies gave no 
indication of funding. Table 1 provides an overall summary of study details. 
 
Weight loss and BMI 
 
Out of the 19 selected studies, 10 reported a significant decrease in body weight 
from baseline in the experimental group (Table 1). While one of the studies noted a 
significant decrease in weight only during the first intervention period of the 
crossover study (Brown et al., 2011), the 9 remaining studies (8 studies lasted for 12 
weeks and one study lasted for 8 weeks) showed a significant decrease in body 
weight by a mean of 1.47 ± 0.58 Kg. Three of these studies used a phenolic 
compound that provided energy (between 85-350 Kcal) (Hollis et al., 2009; Shin et 
al., 2012; Rangel-Huerta et al., 2015). Seventeen studies assessed BMI, of which 7 
demonstrated a decrease by a mean of 0.65 ± 0.55 Kg/m2 from baseline in the 
experimental group. On the other hand, three studies reported a significant increase 
in weight only in the placebo (control) group (mean increase: 1.04 ± 0.54 Kg).  
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Changes in waist circumference 
 
Fourteen studies assessed the effect of polyphenols on WC. Nine studies found a 
significant lowering effect on WC (mean decrease: 2.58 ± 1.33 cm). Eight studies 
lasted for 12 weeks while one study lasted for 8 weeks (noted a significant decrease 
in WC by 0.63 cm) (Table 1). 
 
Changes in body fat percentage and body composition 
 
Twelve studies assessed fat composition as either body fat percentage (N=10) or 
body fat mass (N=2). While 4 studies showed no significant effects on body fat 
percentage, 6 studies showed a decrease in fat percentage by a mean of              
1.86 ± 0.98%. One study reported a significant decrease in fat mass (by 1.03 ± 0.24 
Kg depending on the polyphenol dose). Three studies assessed fat visceral area and 
noted a significant decrease by 9.18 ± 1.2 cm (Table 1). 
 
Discussion 
 
Main findings 
 
The aim of this review was to assess existing human research on polyphenols and 
body weight status. Eligible studies involved the incorporation of polyphenols (in 
different forms) in the context of a normocaloric diet and not as a part of a reduced-
calorie diet or in addition to exercise. This eliminated the effect of weight loss 
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strategies which would mask the effect of polyphenols on weight and body 
composition. Demonstrating a potential effect of polyphenols on obesity would be 
helpful towards integrating polyphenols in weight loss regimens or coupled to 
exercise. 
 
The similarities in the mechanisms of action of polyphenols on obesity provided a 
justification for including different types of polyphenols in the same review. For 
example, phlorotannins, quercetin and phenolic acids have been shown to be 
involved in the inhibition of adipocyte differentiation (Hsu et al., 2007; Jung et al., 
2014; Seo et al., 2015).  Anthocyanins, quercetin and phenolic acids have been 
reported to increase AMPK (adenosine monophosphate-activated protein kinase), 
which is involved in fatty acid oxidation (Pfeuffer et al., 2013; Chang et al., 2014). 
Some polyphenols have been implicated in increasing satiety, reducing energy 
intake (Panickar et al., 2013) and increasing thermogenesis (Meydani et al., 2010; 
Stohs and Badmaev, 2016). The latter mechanisms are involved in body weight 
control. The limited understanding of the mechanisms of actions requires further 
research.  
 
The results of the selected studies do not mostly favour a weight-lowering effect of 
polyphenols in overweight and obese individuals. The weight loss reported by 9 out 
of 19 selected studies ranged between 1.47 ± 0.58 Kg. The duration of the studies 
(4-12 weeks) might provide an explanation for the results obtained. It has been 
indicated that larger longer-term trials with duration of 12 months or more are 
needed to understand the effect of an intervention on weight loss and weight 
management (Headland et al., 2016). The nine studies showed a small body weight 
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reduction, less than previously considered clinically relevant weight loss at 5% 
(Stevens et al., 2006). However, one study showed that a loss of 1 Kg of weight 
could potentially reduce diabetes risk by 16% (Hamman et al., 2006). Therefore, the 
outcomes may not be insignificant in relation to many health outcomes. It is worth 
noting that all these studies were double-blinded which eliminated the expectation 
bias. Nevertheless, there was no sufficient detail on allocation concealment in most 
of the studies. 
A clinically relevant decrease in WC constitutes more than 3 % over the long term 
(Verweij et al., 2013). The mean decrease in WC in selected studies was 2.58 ± 1.33 
cm. As all selected studies included overweight and obese participants, and 
assuming that they have an elevated WC (at least 80 cm), changes reported might 
not be clinically relevant in all studies.  
Among studies that analysed both body weight and body fat composition, 7studies 
showed a significant decrease in both body weight and body fat, while two studies 
reported a significant decrease only in body weight and one study reported a 
significant decrease in body fat percentage (by 1% , p< 0.05), but not body weight. 
Further studies are needed to explain the association between body weight and body 
fat in relation to polyphenol consumption, particularly because the majority of 
mechanisms by which polyphenols are suggested to reduce obesity is through their 
effects on lipid metabolism, such as inhibition of fatty acid oxidation (Dulloo et al., 
1999; Shimoda et al., 2009), and decrease of fatty acid synthesis (Matsui et al., 
2005).   
This review suggests that further research is needed before considering polyphenols 
a complementary approach to aid in weight loss. This hypothesis might be helpful in 
avoiding misleading advertisement currently describing polyphenols as anti-obesity 
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agents. Nevertheless, the effects of polyphenols on cardiovascular risk seem to be 
more established (Dudzińska et al., 2015). Therefore, it could be suggested that 
polyphenols can lower CVD risk by targeting components of the metabolic syndrome 
such as blood pressure and HDL cholesterol (Serban et al., 2015; Santini and 
Novellino, 2016; Ganjali et al., 2017; Patti et al., 2017), while their implication in 
weight loss is less plausible. Meanwhile, a diet rich in polyphenols can be 
recommended as having protective effects on risk factors for CVD but their effects 
on weight loss in humans require further research. 
Among polyphenols, flavonoids and phenolic acids appear to be the most involved in 
obesity and weight control. Subtypes of flavanoids that have been implicated in 
weight loss or change in body composition in the selected studies are catechins, 
phlorotannins, glabridin, anthocyanins, procyanidins and quercetin. Although the 
study by Rangel and Huerta (2015) showed a significant decrease in weight 
following the consumption of orange juice (at two different concentrations of 
flavanones), it is suggested that flavanone is not involved in weight loss. The 
decrease in weight was explained by the decrease in energy intake during the study 
(Rangel-Huerta et al., 2015). However, the latter study lacked a control group which 
could have provided more clarification on the effects of flavanones on body weight. 
Further studies investigating the effect of flavanones on body weight status are 
needed. 
Other polyphenols such as curcumin, flavanols and ellagic acids have also been 
involved in attenuating obesity (Meydani et al., 2010) and are known to exist in 
several commonly consumed foods such as turmeric, grapes, nuts, pomegranate, 
berries, cocoa and chocolate (Daniel et al., 1989; Meydani et al., 2010; Akaberi and 
Hosseinzadeh, 2016; Kunnumakara et al., 2016). As far as we know, limited or no 
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human studies primarily investigating the potential implication of the latter 
polyphenols on obesity and body weight. Cocoa and dark chocolate have been the 
subject of extensive animal and in vitro studies due to their high flavanol content 
(epicatechin, procyandins and quercetin) (Hurst et al., 2008). Although a human 
study demonstrated that 7 days of cocoa supplementation with 2000 mg of 
polyphenols reduced WC (by 1.24±1.45cm, p≤ 0.05) without affecting weight (Di 
Renzo et al., 2013), this significance remains under question due to the short study 
duration and the absence of a control group. Hence, this study was not included in 
the systematic review. 
Catechins in green tea have been the most popular polyphenols studied. Research 
is mostly in favour of their potential effects on lowering weight and adiposity (Nagao 
et al., 2005; Nagao et al., 2007; Wang et al., 2010; Hsu et al., 2008). Nonetheless, a 
meta-analysis suggested that the effects of green tea catechins on body weight are 
more plausible in the Asian population due to a genetic polymorphism that leads to 
differences in the thermogenic effect of green tea (Hursel et al., 2009). This explains 
the consistent results obtained in the Asian populations (Nagao et al., 2005; Nagao 
et al., 2007; Wang et al., 2010; Hsu et al., 2008), while the effects are less consistent 
in western studies (Basu et al., 2010; Brown et al., 2011; Sulliburska et al., 2012). 
Therefore, it is important to find out whether findings about tea and polyphenols can 
be applicable to different regions. However, It seems that when the amount of 
caffeine is controlled, the treatment effect of green tea catechins on obesity was no 
longer apparent (Basu et al., 2010; Brown et al., 2011). This has been reinforced by 
a Dutch study which showed that the effect of green tea was not significant in 
participants with a habitual high caffeine intake (Westerterp-Plantenga et al., 2005). 
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The potential effect of caffeine or a synergistic effect between polyphenols and 
caffeine deserve further investigation.  
Nonetheless, there is evidence to suggest that the role of polyphenols might be 
limited to the prevention of weight gain rather than reducing weight per se. This is in 
line with the majority of animal studies which demonstrated that polyphenols reduce 
weight gain caused by diet-induced obesity. For instance, extracts of epicatechin and 
quercetin and polyphenols in green tea, cocoa, resveratrol, pomegranate and 
curcumin have prevented an increase in weight in animals administered a 
hypercaloric diet, compared to those given a placebo control (no polyphenols) (Lei et 
al., 2007; Ahn et al., 2008; Shao et al., 2012; Gulvady et al., 2013; Tian et al., 2013; 
Dorenkott et al., 2014). This hypothesis provides an explanation for the results 
obtained in the study by Hollis et al. (2009) who showed a significant increase in 
weight only in the group administered grape juice with a negligible amount of 
polyphenols (by 1.6 ± 0.3 Kg, p>0.05). Participants who consumed grape juice with 
polyphenols (934 mg) did not display a significant increase in weight (mean 
difference from baseline: 0.8 ± 0.6 Kg, p<0.05). In their study on licorice flavonoid oil 
(LFO), Bell et al. (2011) noted a significant increase in weight only in the control 
group and suggested that LFO can be helpful in reducing weight gain in periods of 
overfeeding. Additionally, a study that did not meet the inclusion criteria for this 
systematic review showed  that one month of pomegranate juice supplementation 
prevented an increase in weight, BMI and body fat mass in obese participants (mean 
difference from baseline: -0.5 ± 2.3 Kg, -0.2 ± 0.5 Kg/m2, -1.4 ± 3%, respectively, p> 
0.05) compared to the group administered the control juice (weight, BMI and body fat 
mass increased by 1.1 ± 1.3 Kg, 0.4 ± 0.5 Kg/m2, 1.1 ± 1.1%, respectively, p< 0.05) 
(Gonzàlez-Ortiz et al., 2011).  Moreover, the results noted by Brown et al. (2011) led 
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to conclude  that tea catechins may be involved in preventing weight gain during 
periods of positive energy imbalance such as increase in weight during seasonal 
changes, for instance during winter. The current authors have also shown that 400 
mg of flavanols in dark chocolate avoided the increase in weight at the end of a 4-
week study (Mean difference from baseline: -0.01 ± 0.9 Kg, p=0.98) compared to the 
control group (0.44 ± 0.86 Kg, p= 0.009) administered dark chocolate with low 
amount of flavanols (<60 mg) (Farhat et al., 2015). Similar results were noted by 
another study which included overweight and obese individuals and suggested that 
polyphenols can counter the effect of fat and energy contents of the diet (Al Moosawi 
et al., 2012), although there was no data to support this. In view of the outcomes 
noted, further investigation is needed before suggesting a significant effect of 
polyphenols on reducing weight gain in the overweight and obese population. This 
effect could be of importance as it was shown that an increase of 1 Kg of body 
weight can rise coronary mortality risk by 1 - 1.5 % (Jousilhati et al., 1996). With the 
increasing obesity prevalence, mainly due to a positive energy balance 
(Krzysztoszek et al., 2015), polyphenols could then be helpful in preventing small 
increases in weight such as during winter or periods of overfeeding. 
 
Further larger long-term studies (at least 12 months) controlled for energy intake and 
physical activity are required to determine the role of polyphenols in weight 
management. Studies comparing the effect of different polyphenols in periods of 
overfeeding and in periods of steady weight are needed in the overweight and obese 
population. In addition, further research investigating the effects of different doses of 
polyphenols will be helpful to determine the optimal dose of polyphenols for 
maximum benefit. Also, because of the serious effects of certain herbs and the herb-
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drug interactions (Izzo et al., 2016), it is important to consider these side effects 
while recommending some herbal products because of their high polyphenol content. 
It would be important to determine whether polyphenols administered in different 
forms can have different effects. For example, a placebo-controlled study with three 
arms analyzing the effect of polyphenol-rich juice or food (introduced in the context 
of an energy-balanced diet) versus polyphenol extract capsules on body weight and 
composition in the overweight population would be valuable. Based on the results of 
the selected studies in this review, we can hypothesize that the administration of 
polyphenols in various forms does not differently affect their weight-lowering 
properties. 
Furthermore, studies with complete data, including information about concealment 
and data analysis are needed. Breakdown of the amount of polyphenols in both 
experimental and control group is required. It is also worth noting that polyphenols 
can be affected by several factors such as the timing of intake, as one of the 
mechanisms by which polyphenols reduce obesity is through their potential effects 
on digestive enzymes such as inhibition of protease and lipase (McDougall et al., 
2005). Therefore, it is important to test match for these differences in future studies. 
Lastly, it would be important to determine whether there is a combination effect of 
different polyphenols or polyphenol-rich foods on body weight status, especially 
since many of these polyphenols are available combined in nature, and whether an 
adaptation to the effect of polyphenols occurs over time. This would be helpful to 
establish conclusions regarding different foods and beverages such as apple juice, 
green tea as well as polyphenol extracts.  
 
Strength and limitations 
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One of the review’s potential weaknesses is that the comparison of significant effects 
between studies was based on different statistical comparisons used. In fact, 9 
studies considered between-group differences, while 10 studies considered within-
group differences. This has possibly affected the generation of hypotheses and 
conclusions. For instance, in the study by Chang et al. (2014), paired-t-tests showed 
a significant difference in body weight, BMI and waist-to-hip ratio (p< 0.05), while 
between-group analysis showed significant difference only in WC, waist-to-hip ratio 
and body fat percentage (p<0.05). In addition, Tominaga et al. (2009) did not 
analyse whether there is a significant interaction between different doses of 
polyphenols and time on the effects noted. This is an important point that needs to 
be emphasized in both future systematic reviews and trials. Another limitation is the 
duration of the studies (4-12 weeks) which might not have been sufficient to 
understand the effect of polyphenol on body weight. Furthermore, most of the 
studies measured the outcomes on limited time points (baseline and week 12 were 
considered in 8 studies). Five other studies have taken measurements at multiple 
time points but did not include these data in the analysis.  This an important point to 
consider in future studies. A suggestion would be to analyse the study parameters at 
2-week interval in long term studies. Also, diet advice to participants was not 
properly described in the majority of selected studies.  A further limitation is the 
restriction of the review to the English language, as the studies on polyphenols are 
popular in the Asian population. 
 
Conclusion 
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This review of selected studies suggests that further research is needed before 
supporting the implication of polyphenols in weight loss and recommending 
polyphenols as a potential complementary approach in weight-loss diets. There is an 
indication to suggest that the benefits of polyphenols might only be restricted to the 
counteraction of the small increases in body weight and fat resulting from seasonal 
changes (such as during winter) or periods of overfeeding. Long-term studies 
involving a large cohort and controlling for diet and exercise are needed in order to 
confirm the potential effect of polyphenols on obesity in humans. The genetic 
differences between populations also need to be considered. 
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Table 1: Overall details of included studies 
 
Study/participants 
characteristics 
Length 
(weeks) 
Intervention Energy 
content
/day  
Polyphenol 
content per 
day//type (s) 
Anthropometri
c 
measurements 
Baseline  Post-intervention (Mean change 
from Baseline ) 
Dallas et al., 2014 (26) 
France 
double-blinded 
controlled parallel 
study 
N=95 (42% men) 
Age: 22-45 years 
BMI: 26 - 29.9 kg/m2 
12 Two capsules of a) 
citrus polyphenolic 
extract with red 
orange, grapefruit, 
sweet orange and 
guarana (Sinetrol-
Xpur) or b) 
maltodextrin 
placebo) 
NEGL a)900 mg / 
Catechin (~810 
mg), 
Flavanones (at 
least 20% 
(naringin) 
b) NEGL 
Body weight 
 
BMI  
 
WC  
 
Waist-to-hip 
ratio 
BF % 
 
 
EG: 78.14 ±1.35 
CG: 77.39 ± 1.23 
EG: 27.58 ± 0.16  
CG: 27.27 ± 0.14 
EG: 88.68 ± 1.05 
CG: 88.44 ± 1.09 
EG: 0.813 ± 0.113 
CG: 0.809 ± 0.113 
EG: 37.97 ± 1.59 
CG: 36.87 ± 1.48 
EG: 75.52 ± 1.25* (-2.62) 
CG: 75.78 ± 1.23  (-1.58) 
EG: 26.39 ± 0.33 (-1.19) 
CG: 26.12 ± 0.35   (-1.15) 
EG: 83.53 ± 0.87* (-5.15) 
CG: 87.02 ± 1.02   (-1.42) 
EG:0.784 ± 0.155 (-0.03) 
CG:0.808 ± 0.101 (-0.001) 
EG: 34.36 ± 1.49* (-3.01) 
CG: 35.85 ± 1.51  (-1.02) 
Chang et al., 2014  
(27) Taiwan  
double-blinded 
controlled parallel 
study 
N= 36 (58% men) 
Age: 18-65 years 
BMI ≥ 27 kg/m2 
12 6 capsules of a) 
Hibiscus sabdariffa 
extract (HSE) or b) 
starch (placebo) 
NEGL a)152 mg / 
Flavonoids 
(~39mg) 
Anthocyanins (68 
mg) 
Phenolic acids (46 
mg)  
b) NEGL 
Body weight 
 
BMI 
 
WC 
 
Waist-to-hip  
Ratio 
BF % 
 
 
EG: 88.52 ± 15.96 
CG:84.93 ± 12.79 
EG:31.51 ± 4.01 
CG:30.91 ± 3.71 
EG:98 ± 11.75 
CG:95.32 ± 10.43  
EG:0.91 ± 0.07  
CG:0.9 ± 0.06 
EG:37.37 ± 6.22  
CG: 38.44 ± 9.8 
EG: 87.28 ± 16.02* (-1.24) 
CG: 84.27 ± 13.14 (-0.66)  
EG: 31.09 ± 4.23* (-0.42) 
CG: 30.65 ± 3.76 (-0.26)  
EG: 97.16 ± 10.94 (-0.84)  
CG: 95.94 ± 10.25 (0.62)  
EG: 0.9 ± 0.06* (-0.01) 
CG: 0.9 ± 0.06 (0) 
EG:36.67 ± 6.61 (-0.7)  
CG: 39.08 ± 9.82 (0.64) 
Hollis et al., 2009  (28) 
USA 
double-blinded 
controlled parallel 
study 
N= 76 (61% men) 
Age: 18-50 years 
BMI 25-29.9 kg/m2 
 
12 a) 480 ml of 
Concord Grape 
Juice (CGJ) or b) 
480 ml of substitute 
(polyphenol-free) 
grape flavored drink 
(SGD; control) or c) 
no beverage (NTG) 
CGJ: 
350 
Kcal; 
SGJ: 
350 
Kcal 
 a)934 mg / 
anthocyanins (191 
mg), procyanidins 
(307 mg) 
catechin, 
quercetin, & 
myricetin. 
b) NEGL 
c) NEGL 
Body weight 
 
 
BMI 
 
 
WC 
EG: 79 ± 8.4   
CG: 79 ± 10.7  
 
EG: 27 ± 1.6 
CG: 27 ± 1.5 
 
EG: 83.31 ± 6.6 
CG: 84.07 ± 7.62 
EG : 79.7 ±  9.5 (0.7)   
CG: 80.6 ± 11.2* (1.6) 
 
EG: :27.1 ±  2.0 (0.1)  
CG: 27.2 ± 1.9 (0.2)  
 
EG: 82.04 ± 7.1* (-1.57) 
CG: 83.31 ± 8.64 (-0.76) 
25 
 
Pfeuffer et al, 2013 
(29) 
Germany 
double-blinded 
crossover study 
N= 49 (100 % males) 
Age: 48 ± 68 years 
BMI: 26.3 ± 0.3 kg/m2 
Two 8-
week 
treatment 
(3 week 
washout 
period) 
 
Six capsules of a) 
quercetin dihydrate 
(150 mg/day) or  b) 
placebo  
NEGL a)150mg / 
quercetin 
b) NEGL 
Body weight 
 
BMI 
 
WC 
 
┼ 
 
┼ 
 
┼ 
NS┼ 
 
NS┼ 
 
┼ (-0.63)* 
Shin et al., 2012 (30) 
USA 
double-blinded parallel 
controlled study 
N= 97 (34% males) 
Age: 40.5 ± 9.2 years  
BMI: 26.5 ± 1.6 kg/m2 
 
 
 
 
12 246 ml of 
a)Ecklonia cava 
Polyphenol extract 
(ECP) drink low 
dose  b) ECP high 
dose or c) control 
drink (sugars, 
sodium chloride, 
citric acid, vit C and 
lemon flavour) 
~ 85 
Kcal (a, 
b,c) 
a)ECP low dose: 
72 mg/ 
Phlorotannins 
(unique 
polyphenols) 
b) ECP high dose: 
144 mg) / 
Phlorotannins  
c) NEGL 
Body weight 
 
 
BMI 
 
 
Body fat % 
 
 
WC 
 
 
Waist-to hip 
 ratio 
ECP HD: 71.2 ± 9.4 
ECP LD: 70.5 ± 10 
CG: 71.3 ± 9.4  
ECP HD: 31.4 ± 5.4 
ECP LD: 26.4 ± 1.7 
CG:26.5 ± 1.5 
ECP HD: 31.4 ± 5.4 
ECP LD: 30.8 ± 5.3  
CG: 31.7 ± 5.2  
ECP HD: 90.7 ± 7.1 
ECP LD: 90.4 ± 6.8 
CG: 90.8 ± 6.3 
ECP LD:90.2 ± 5.9 
ECP LD: 89.9 ± 5.6 
CG: 90.3 ± 4.9 
ECP HD: 69.9 ±  9.6* (-1.3)  
ECP LD: 69.6 ± 9.6* (-0.9) 
CG: 70.9 ± 9.7 (-0.4) 
ECP HD: 29.3 ± 5.4* (-2.1) 
ECP LD: 26.2 ± 1.7* (-0.2) 
CG: 26.4 ± 1.8 (-0.1) 
ECP HD: 29.3  ± 5.4* (-2.1) 
ECP LD: 29.9 ±  5.4* (-0.9)  
CG: 31.3 ± 5.3* (-0.4) 
ECP HD: 89.3 ± 6.3* (-1.4)  
ECP LD: 89.6 ± 5.9* (-0.8) 
CG: 90.3 ±  6* (-0.5) 
ECP LD: 88.8 ± 5.5* (-1.4)   
ECP LD: 88.9 ± 5.8* (-1) 
CG: 89.7 ± 5 (-0.6) 
Rangel-Huerta et al., 
2015 (31), Spain 
Double-blinded 
crossover study 
N= 100 (8 % males) 
Age: 50 ± 3 years 
25≤ BMI < 40 kg/m2 
Two 12-
week 
period (7 
week 
washout 
period) 
500 ml of orange 
juice  
a)normal 
polyphenol 
concentration (NPJ) 
b) high polyphenol  
concentration (HPJ) 
 NPJ: 
245 
Kcal ;  
 
HPJ : 
303 
Kcal 
a)NPJ : 
299.5 mg/ 
Flavanones (237 
mg of hesperidin 
45 mg) of 
narirutin, and 17 
mg of didymin) 
 
b)HPJ: 742.5 mg/ 
Flavanones 
(582.5 mg  mg of 
hesperidin, 125 
mg of narirutin, 
and 34 mg 
didymin) 
 
 
 
 
Body weight 
 
 
BMI 
 
 
 
WC 
NPJ: 90.4 ± 1.5 
HPJ: 90.6 ± 1.5 
 
NPJ: 32.5 ± 0.4 
HPJ: 32.6 ± 0.4 
 
NPJ: 99.1 ± 1.3 
HPJ: 99.4 ± 1.1 
NPJ: 89.1 ± 1.5 * (-1.3) 
HPJ: 88.88 ±  1.5 * (-1.8) 
 
NPJ: 32.0 ± 0.4* (-0.5)  
HPJ: 31.9 ± 0.4* (-0.7) 
 
NPJ: 95.1 ± 1.2 *(-4.0) 
HPJ: 95.6 ± 1.1* (-3.8) 
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Poulsen et al., 2013 
(32) 
Denmark 
double-blinded parallel 
controlled study 
N= 24 (100 %males) 
Age: 38.4 ± 2.6 years  
BMI: 34.2 ± 0.7 kg/m2 
 
4 Four capsules of a) 
resveratrol or b) 
placebo 
 a) 500 mg of 
resveratrol 
b) NEGL 
Body weight 
 
BMI 
 
BF % 
 
Visceral fat 
volume 
EG: 107.1 ± 2.7 
CG: 115. 9 ± 3.6 
EG: 32.5 ± 0.6 
CG: 35.9 ± 1.2 
EG:30. 2 ± 0.7 
CG: 32.3 ± 1.4 
EG: 4996 ± 876 
CG: 4285 ± 585 
NS ┼ 
 
NS ┼ 
 
NS ┼ 
 
NS ┼ 
Nagao et al., 2005 (33) 
Japan 
Double-blinded parallel 
controlled study 
N= 35 (100 % males) 
Age: 24-46 years 
BMI: 24.9 ± 0.4 (EG) 
BMI: 25 ± 0.4 (CG) 
(Kg/m2) 
12 One bottle (340 ml) 
of a) Oolong tea 
with amount of 
catechins or b) 
Oolong tea with low 
amount of catechins 
NEGL a) 690 mg of 
catechins 
b) 22 mg of 
catechins  / CT, 
CG, GC, GCG, 
EC, ECG, EGC, 
EGCG 
 
Body weight 
 
BMI 
 
WC 
 
Body Fat mass 
EG: 73.9 ± 1.8 
CG: 73.8 ± 1.3 
EG: 24.9 ± 0.4 
CG: 25 0 ± 0.4 
EG: 87. 9 ± 1.4 
CG: 87.8 ± 1.1 
EG: 19.7 ± 0,8 
CG: 19.5 ± 1 
EG: 71.5 ± 1.7 * (-2.4) 
CG: 72.5 ± 1.4 (-1.3) 
EG: 24.1 ± 0.4 *(-0.8) 
CG: 24.6 ± 0.4 (- 0.4) 
EG: 84.5 ± 1.3*(- 3.4) 
CG: 86.2 ± 1.2 (-1.6) 
EG: 18.3 ± 0.9* (-1.4) 
CG: 18.8 ± 1.1 (-0.6) 
Nagao et al., 2007 (11) 
Japan 
Double-blinded 
controlled study 
N= 240 (58% males) 
Age: 41.7 ± 9.9 years 
BMI: 26.8 ± 2.0 kg/m2 
12  One can of  
a) Green tea (340 
ml) high in 
catechins or b) 
Greetn tea low in 
catechins  
 
NEGL a)583 mg 
catechins  b) 96 
mg of catechins/ 
CT, CG, GC, 
GCG, EC, ECG, 
EGC, EGCG 
Body weight 
 
BMI 
 
WC 
 
BF % 
 
Visceral fat 
area 
EG: 73.3 ± 9.7 
CG:72.1 ± 10 
EG: 26.9 ± 1.9 
CG:26.7 ± 2.1 
EG:87.2 ± 5.2 
CG:86.5 ± 6.1 
EG:30.7 ± 6.4 
CG:30.7 ± 5.4 
EG:109.2 ± 42.3 
CG: 107.7 ± 44 
EG: 71.6 ± 9.8* (-1.7)  
CG: 72.1 ± 10.3 (-0.1) 
EG: 26.2 ± 1.9* (-0.6) 
CG: 26.6 ± 2.2 (-0.0) 
EG: 84.7 ± 5.5* (-2.5) 
CG: 86.5 ± 6.7 (0) 
EG: 28.3  ±  6.1* (-2.5) 
CG: 30  ±  5.6* (-0.7)  
EG: 98.9  ±  38.6* (-10.3) 
CG: 103.8 ± 38.9  (-3.9) 
Wang et al., 2010 (34) 
China 
Double-blinded parallel 
controlled study 
N= 182 (27%males) 
Age: 18-55 years  
BMI: 24-35 kg/m2 
~12 Tea bags infusion : 
a) Green tea 1 
(GT1);  b) GT2 c) 
GT3 or  
c) control 
NEGL GT1: 458 mg; 
GT2: 468 mg ; 
GT3: 886 mg: 
Control: 30mg/ 
CT, CG, GC, 
GCG, EC, ECG, 
EGC, EGCG 
Body weight 
 
 
 
WC 
 
 
 
BF % 
 
 
 
Intra-
abdominal fat  
 
GT3: 71.1 ± 11.9 
GT2: 71.5 ± 11.8 
GT1: 71.4 ± 9.8 
CG:   69.7 ± 8.9      
GT3: 95.5 ± 6.9  
GT2: 95.9 ± 7 
GT1: 96.1 ± 5.8 
CG:   94.5 ± 6 
GT3: 32.7 ± 5.3 
GT2: 33.1 ± 5 
GT1: 32.7 ± 5.1 
CG:  33.2 ± 4.7 
GT3: 83.6  ± 3.2 
GT2: 84.7  ± 3.1 
GT1: 85  ± 2.8 
GT3: 69.9  ± 12.1*(-1.2) 
GT2: 70.7  ±  11.7 (-0.8) 
GT1: 70.7  ±  10.1 (-0.7) 
CG:   69.8 ± 9.1 (0.1) 
GT3: 93.6  ± 7* (-1.9)  
GT2: 94.6  ±  7 (-1.3) 
GT1: 95  ±  6.2 (-1.1)  
CG:   94.3  ± 5.8 ( -0.2) 
GT3: 32.2  ±  5.2 (-0.5)  
GT2: 32.2  ±  4.9 (-0.9) 
GT1: 32 ± 5.1 * (-0.7) 
CG:   33  ±  4.7 ( -0.2)  
GT3: 78 ± 3.4* (-5.6) 
GT2: 81.1  ±  3.1 (-3.6) 
GT1: 81  ± 3 (4.1)  
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CG:   80.4  ± 3.1 CG:   79.3  ±  2.9 (-1.1) 
Brown et al., 2011 (35) 
UK 
Double-blinded cross-
over controlled study 
N= 69 (100% males) 
Age: 40-69 years  
28 ≤ BMI ≤38 kg/m2 
 
Two 6-
week 
period (2 
week 
washout 
period) 
Capsules of a) 
decaffeinated green 
tea extract (530mg) 
b) lactose (placebo) 
NEGL 530 mg catechins/ 
CT (6.15 mg), CG 
(0.16 mg), GC 
(10.7 mg), GCG 
(6.7 mg), EC (46 
mg), ECG (32 
mg), EGC (86 
mg), EGCG (216 
mg) 
b) NEGL 
Body weight 
 
EG:   101.3 ± 11.4 
CG:   100.2 ± 11.1 
 
 
EG:   ┼  (-0.64)* ‡ 
CG:   ┼ (0.53)* ‡ 
 
Basu et al., 2010 (36) 
USA 
Single-blinded 
controlled parallel 
study 
N=35 (23% men) 
Age: 42.5 ± 1.7 years 
BMI 36.1 ± 1.3 kg/m2 
8 a)Four cups of 
decaffeinated green 
tea beverage or b) 2 
capsules of green 
tea extract capsules 
or c) water (4 cups) 
NEGL        a)928mg of   
catechins  
b)870 mg/ CT, 
CG, GC, GCG, 
EC, ECG, EGC, 
EGCG 
c) NEGL 
Body weight 
 
 
BMI 
 
 
WC 
 
 
BF %  
 
GT: 96.4 ± 4.7 
GTE: 106.2 ± 7.5 
Control: 102.7 ± 6.6 
GT:34.6 ± 1.5 
GTE: 38 ± 2.3 
Control: 36.4 ± 2.8 
GT:105 ± 2.8 
GTE: 115 ± 6.4 
Control: 108 ± 5.08 
GT: 42 ± 2.8 
GTE: 42 ± 2.8 
Control: 44 ± 3.4 
   ┼ # 
Hsu et al., 2008 (37) 
Taiwan 
Double-blinded 
controlled parallel 
study 
N=100 (0 % men) 
Age: 43 ± 11.8  years 
BMI: 30.8 ± 4.1 kg/m2 
12 Three capsules of 
a) Green tea extract 
(GTE) 
b) cellulose 
(placebo)   
NEGL a) 205 mg of     
catechins/ CT 
(2.76 mg) , CG 
(2.05 mg), GC 
(20.5 mg), GCG 
(9.16 mg), EC (23 
mg), ECG (10.6 
mg), EGC (12.3 
mg), EGCG (125 
mg) 
b) NEGL 
 
Body weight 
 
BMI  
 
WC 
EG: 78.5 ± 10.3 
CG:76.3 ± 14.5 
EG: 31.2 ± 3.5 
CG: 30.5 ± 4.6 
EG: 94.7 ± 7.7 
CG: 93 ± 12.6 
EG: 78.3 ± 10.6 (-0.15) 
CG: 76.2 ± 14.4 (-0.03) 
EG: 31.1 ± 3.7 (-0.06) 
CG: 30.5 ± 4.6 (-0.006) 
EG: 93 ± 8.5 *(-1.7 ) 
CG: 91.7 ± 11.5 (1.3) 
 
 
 
Sulliburska et al., 
2012 (38) 
Poland 
Double-blinded 
controlled parallel 
study 
N=46 (50 % men) 
Age: 30-60 years 
12 One capsule of  
a) Green tea extract 
(GTE) or b) placebo 
capsules 
NEGL  a) 379 mg/ CT, 
CG, GC, GCG, 
EC, ECG, EGC, 
EGCG (208 mg) 
b) NEGL 
 
BMI 
 
 
WC 
EG: 32.7 ± 2.4 
CG: 33.45 ± 2.7 
 
EG: 101.8 ± 6.4 
CG:105 ± 6.5 
EG: 31.7 ± 2.29 (-1) 
CG: 33.36 ± 2.66 (-0.09) 
 
EG: 101.15 ± 6.42 (-0.65) 
CG: 105.02 ± 6.1 (-0.02) 
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BMI ≥ 30 kg/m2 
Tominaga et al., 2006 
(39) 
Japan 
Double-blinded 
controlled parallel 
study 
N=103 (61% men) 
Age: 46.1 ± 1.2 years 
BMI 26.5 ± 0.2 kg/m2 
12 One capsule of a) 
licorice flavonoid oil 
(LFO) or b) MCT+ 
beeswax (placebo)  
NEGL 24 mg/ flavonoids 
(Glabridin) 
Body weight 
 
 
BMI 
 
 
 
 
EG: 72.69 ± 1.21 
CG: 72.71 ± 1.13 
 
EG: 26.37 ± 0.21 
CG: 26.5 ± 0.2 
EG: ┼ NS 
CG:  (1) * 
 
EG: ┼ NS 
CG: ┼ (0.5*)  
: 
Tominaga et al., 2009 
(40) 
Japan 
Double-blinded 
controlled parallel 
study 
N=84 (67 % men) 
Age: 40-60 years 
BMI 24 - 30 kg/m2 
8 a) 300 mg of licorice 
flavonoid oil (LFO)  
b) 600mg of LFO or 
c) 900 mg LFO d) 
placebo (MCT+ 
beeswax) 
NEGL   1 % Glabridin 
per LFO solution 
Body weight 
 
 
 
 
BMI 
 
 
 
 
Body fat mass 
 
 
 
 
Visceral fat 
area 
 
 
 
 
CG:71.13 ± 2.2 
LFO: 300mg: 71.09 ± 1.98 
LFO 600 mg: 71.88 ± 1.71 
LFO 900: 72.79 ± 1.82 
 
CG::26.51 ± 0.34 
LFO 300mg: 26.28 ± 0.31 
LFO 600 mg: 26.33 ± 0.29 
LFO 900mg: 26.22 ± 0.3 
 
CG::22.65 ± 1.12 
LFO 300mg: 22.56 ± 1.29 
LFO 600 mg: 21.46 ± 0.92 
LFO 900 mg: 22.59 ± 0.9 
 
CG: 115.26 ± 10.07 
LFO 300mg: 120.13 ± 10.6 
LFO 600 mg: 117.16 ± 6.3 
LFO 900 mg: 122.37 ± 8.2 
CG: 73.39 ± 2.22 (2.26) 
LFO 300 mg: 70.81 ± 1.97 (-0.28) 
LFO 600 mg: 71.68 ± 1.68 (-0.2) 
LFO 900: 72.01 ± 1.81* (-0.78) 
 
CG: 26.59 ± 0.33 (0.08) 
LFO 300 mg: 26.17 ± 0.32 (-0.11) 
LFO 600 mg: 26.27 ± 0.3 (-0.06) 
LFO 900 mg: 25.97 ± 0.3* (-0.25) 
 
CG: 22.3 ± 1.24 (-0.35) 
LFO 300mg: 21.64 ± 1.31*(-0.92) 
LFO 600 mg: 20.53 ± 0.98*(-0.93) 
LFO 900 mg: 21.7 ± 0.91* (-0.89) 
 
CG: 110.58 ± 9.67 (-4.68) 
LFO 300mg:116.03 ± 10.57(-4.1) 
LFO 600 mg: 117.49 ± 7.1(0.33) 
LFO 900 mg:113.02 ± 7.72* 
(9.35) 
 
Bell et al., 2011 (41) 
USA 
Double-blinded parallel 
controlled study 
N= 22  
Age: 20-53 years  
BMI: 25-36 kg/m2 
8 Three capsules of 
a) Licorice 
Flavonoid oil (LFO) 
(300 mg) or b) 
placebo (MCT + 
beeswax) 
NEGL 30% polyphenols / 
flavonoids (3% 
glabridin) 
Body weight 
 
BMI 
 
WC 
 
BF % 
EG:88.7 ± 4 
CG:92.3 ± 2.9 
EG:29.4 ± 1.3 
CG:30.2 ± 1.2 
EG:88.5 ± 3.2  
CG: 90.7 ± 2 
EG:33 ± 2.9  
CG:32.1 ± 2.1  
EG: 88.6 ± 3.7 (-0.1) 
CG: 92 ± 3 (-0.3) 
EG: 29.4 ± 1.3 (0)  
CG: 30.1 ± 1.3 (-0.1) 
EG:88.9 ± 3 (0.4) 
CG: 90.9 ± 2.1 (0.2)  
EG: 32.7 ± 3.2 (-0.3)  
CG: 32.2 ± 2.1 (0.1)  
Barth et al., 2012 (42)  
Germany 
Blinded parallel 
controlled study 
4 a)Polyphenol-rich 
cloudy apply juice 
(CLoA) (750 ml) or 
a) : 373 
Kcal/ b) 
CB:353 
Kcal 
a) 802.5 mg/ 
phenolic acids, 
quercetin 
b) NEGL 
Body weight 
 
BMI 
 
EG: 99 ± 14.2 
CG: 97.6 ± 13 
EG:31.1 ± 3.6 
CG:30.5 ± 3 
EG: 99.3 ± 14.3 (0.3)  
CG: 97.8 ± 12.9 (0.2)  
EG:: 31.1 ± 3.6 (0) 
CG 30.6 ± 3.2 (0.1)  
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N= 68 (100% males) 
Age: 23-69 years  
BMI > 27 kg/m2 
b)control beverage  
(CB) 
WC 
 
Body fat % 
EG:107.3 ± 9.9 
CG:106.9 ± 7.9 
EG:29.3 ± 3.6 
CG:29 ± 2.7 
EG: 107.4 ± 9.7 (0.1)  
CG: 107.3 ± 7.9 (0.1)  
EG: 28.3 ± 3.9 (-1)* 
CG: 28.8 ± 2.7 (-0.2)  
Akazome et al., 2010 
(43) 
Japan 
double-blinded 
controlled parallel 
study 
N=94 (60 % men) 
Age: 45.8 ± 8.2 years 
BMI: 27.2± 1.6 kg/m2 
12 Beverage (340 g) 
containing a)apple 
polyphenols or b) 
no polyphenols 
(placebo) 
 NEGL  600 mg/ Body weight 
 
BMI 
 
WC 
 
Waist/hip ratio 
 
Body fat % 
 
Visceral fat 
area 
 
EG: 74.1 ± 8.7 
CG: 75.2 ± 8.5 
EG:27 ± 1.7 
CG:26.9 ± 1.6 
EG: 94.3 ± 5 
CG:94.3 ± 4.5 
EG: 0.951 ± 0.041 
CG: 0.951 ± 0.041 
EG: 28.3 ± 5.8 
CG: 28.8 ± 6.2 
EG: 106.1 ± 34.3 
CG: 99.2 ± 31.5 
EG: 73.2 ± 8.7* (-0.9) 
CG: 75.2 ± 8.2 (0) 
EG:26.7 ± 1.6* (- 0.3) 
CG:26.9 ± 1.5 (0) 
EG: 92.1 ± 4.7* (-2.2) 
CG:94.2 ± 4.2 (-0.1) 
EG: 0.942 ± 0.042* (-0.009) 
CG: 0.952 ± 0.42 (0.001) 
EG: 28.9 ± 5.6 (0.5) 
CG: 29.8 ± 6.1* (1) 
EG: 98.2 ± 28.2* (-7.9) 
CG: 101.3± 35.2 (2.1) 
BF: Body Fat; CG: Control group; CT: Catechins; CG: Catechin gallate ;CloA:  Polyphenol-rich cloudy apply juice; GC: Gallocatechin; GCG: Gallocatechin gallate; EG: 
Experimental group; EC: Epicatechin; ECG: Epicatechin gallate; ECP: Ecklonia cava polyphenols; EGG: Epigallocatechin; EGCG: Epigallocatechin gallate; GT: Green tea; 
GTE: Green tea extract; High polyphenol concentration (HPJ);  HSE: Hibiscus sabdariffa extract; LFO: Licorice flavonoid oil; ; MCT: Medium-chain Triglycerides; NEGL: 
Negligible; Normal polyphenol concentration (NPJ); NS: Non significant; WC: Waist circumference 
Body weight (Kg), BMI (kg/m2), Waist circumference (WC), Body fat mass (Kg), visceral/abdominal fat area (cm2), Visceral fat volume area (cm3) 
*significant difference p<0.05 
┼ missing data 
‡ Significant effects (p< 0.05) only in intervention period 1 
# No significant differences in all parameters from baseline between experimental group and control group.
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